• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.




    Baltimore, MD (July 11, 2012)  During the 2012 legislative session the General Assembly passed HB 1141, MHCC- Cardiac Surgery and PCI Services, which establishes a new legal framework for the oversight of percutaneous coronary intervention (PCI) services and cardiac surgery. The Maryland Health Care Commission (MHCC) has been tasked with implementation of HB 1141, including convening a clinical advisory group of both in-state and out-of-state experts to provide guidance to the Commission on appropriate standards for PCI and cardiac surgery.

    This 26 member advisory group will provide input to MHCC on standards for both the establishment of cardiac surgery and PCI programs and ongoing performance standards for existing and new programs.  The standards will reflect changes in the scientific consensus regarding PCI at non-surgical hospitals and also take into account current findings regarding quality of care in cardiac surgery and related services. The effort requires experts who can provide scientific and clinical practice perspectives, give input on appropriate peer review practices, and also speak to regulatory experience in other states.

    Clinical experts were nominated by Maryland's  acute care hospitals, the American College of Cardiology, the Society for Cardiovascular Angiography and Intervention, the Society of Thoracic Surgeons, the American Heart Association, MedChi - the Maryland Medical Society, the Maryland Institute for Emergency Services Systems and the Department of Health and Mental Hygiene.  The appointees include representatives from in and outside the state and are broadly representative of the hospitals that offer cardiac services, the providers that deliver cardiac services, and consumer groups that advocate on behalf of patients with cardiac conditions.  The experience of in-state experts reflects the range of how cardiac services are delivered in hospital systems and independent hospitals in Maryland. Some operate in hospitals offering both PCI and cardiac surgery, others work in hospitals offering PCI without cardiac surgery, and several operate in hospitals may seek to offer PCI in the future.  Attached is the list of the membership. Dr Loren F. Hiratzka, Medical Director of Cardiac Surgery at Tri-Health in Cincinnati, Ohio, and Dr. David O. Williams, Director of the Cardiovascular Catheterization Laboratory at Memorial Hospital of Rhode Island, have agreed to serve as co-chairs of the group. Attached are short biographies of both chairs and a full list of the advisory group.

    Loren F. Hiratzka, MD
    Dr. Hiratzka is an active cardiothoracic surgeon in Cincinnati, Ohio and is Medical Director of Cardiac Surgery at Tri-Health, Inc. (Bethesda North Hospital and Good Samaritan Hospital) in Cincinnati.  He is Assistant Professor of Clinical Surgery at the University Of Cincinnati College Of Medicine.  Dr. Hiratzka serves on the Writing Committee to revise the American College of Cardiology (ACC)/American Heart Association (AHA)/Society of Thoracic Surgeons (STS) Practice Guidelines on Coronary Bypass Graft Surgery; he was recently the STS representative to the American College of Surgeons Committee to develop the Surgical Consumer Assessment of Health Providers and Systems survey for the Agency for Healthcare Research and Quality, and has served on the AHA Science Advisory and Coordinating Committee.
    David O. Williams, MD
    Dr. Williams is Director of the Cardiovascular Catheterization Laboratory at Memorial Hospital of Rhode Island, as well as an interventional cardiologist in the Division of Cardiovascular Medicine at Brigham and Women's Hospital in Boston.  He is also Professor of Medicine at the Harvard Medical School, Division of Brigham and Women's Hospital. In 2002-03, Dr. Williams was the Chairman of the Interventional Subcommittee of the MHCC Advisory Committee on Outcome Assessment in Cardiovascular Care, and so has a long history of providing input and guidance to MHCC cardiovascular quality efforts. 
      **Please click here for list of Advisory Members**